Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Equity Income (2024 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Equity Income for 2 consecutive years, with -$4.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Income fell 118.76% year-over-year to -$4.6 million, compared with a TTM value of -$14.2 million through Dec 2025, down 575.9%, and an annual FY2025 reading of -$14.2 million, down 575.9% over the prior year.
  • Equity Income was -$4.6 million for Q4 2025 at Tandem Diabetes Care, down from -$2.7 million in the prior quarter.
  • Across five years, Equity Income topped out at -$2.1 million in Q4 2024 and bottomed at -$4.6 million in Q4 2025.